Tag: vaccines

And so it begins … the damage caused by the C19 injections requires an increase in – diagnostic, mitigation of symptoms with rehabilitation – protocols and qualified staff – until a cure is found

From here (h/t (100) AUCKLAND HOSPITAL CONFIRMS WAITING TIME ON CARDIOLOGY APPOINTMENT LIST… (substack.com): )

(11) NZ and the MRNA on X: “AUCKLAND HOSPITAL CONFIRMS WAITING TIME ON CARDIOLOGY APPOINTMENT LIST… Our vaccine injured Kiwi called Auckland Hospital this morning to confirm how long she would have to wait to see a Cardiologist as an outpatient? She did this following information from her doctor….that… https://t.co/6gNJH4QZwT” / X (twitter.com)

“AUCKLAND HOSPITAL CONFIRMS WAITING TIME ON CARDIOLOGY APPOINTMENT LIST…

Our vaccine injured Kiwi called Auckland Hospital this morning to confirm how long she would have to wait to see a Cardiologist as an outpatient?

She did this following information from her doctor…. that was so extreme she decided to check the facts herself.

Today Auckland Hospital confirms A MINIMUM OF TWO YEAR WAIT TO SEE A CARDIOLOGIST AS AN OUTPATIENT

I wonder how many people will die in the meantime?”

Keep reading

COVID Vaccine Gene Could Integrate Into Human Cancer Cells: Researcher

Following his discovery of DNA contamination in COVID-19 mRNA vaccines, genomic researcher Kevin McKernan has recently found that the DNA in these vaccines can potentially integrate into human DNA.

The COVID-19 vaccine spike sequence was detected in two types of chromosomes in cancer cell lines following exposure to the COVID mRNA vaccine. Mr. McKernan’s findings, which he presents on his Substack blog, haven’t been peer-reviewed.

These are expected to be “rare events,” but they can happen, Mr. McKernan told The Epoch Times.

DNA Integration

Since the introduction of the COVID-19 mRNA vaccines, some members of the public have been concerned that the vaccines may modify the human gene by combining their sequences with the human genome.

“Fact-checkers” refuted this, stating that mRNA cannot be changed into DNA. Yet Mr. McKernan’s earlier work shows that DNA in the vaccine vials may be capable of changing human DNA.

Biologist and obstetrics-gynecology professor Ulrike Kämmerer at the University Hospital of Würzburg conducted earlier stages of this research.

Exposing breast and ovarian human cancer cells to Pfizer and Moderna mRNA vaccines, Ms. Kämmerer found that around half of the cells expressed the COVID-19 spike protein on their cellular surface, indicating they had absorbed the vaccines.

Keep reading

Influenza Vaccines Only 42 Percent Effective in Adults This Year

The influenza vaccines currently being administered in the United States are estimated by the U.S. Centers for Disease Control and Prevention (CDC) to be 42 percent effective in adults. This is an interim estimate for the 2023-2024 “flu season” published in the agency’s Morbidity and Mortality Weekly Report (MMWR) on Feb. 29, 2024.1 2 3

By “effective,” the CDC is referring to reducing the risk of influenza-related hospitalizations or “medically attended influenza virus infection, not actually preventing influenza infections—notably influenza A (H1N1) and B (Victoria lineage).1 In its report, the agency stated:

These findings indicate that the 2023–24 seasonal influenza vaccine is effective at reducing the risk of influenza-associated outpatient visits and hospitalization.1

Less Than 25 Percent of Suspected ILI Cases are Influenza

Most influenza-like-illness (ILI) which occurs during the “flu season” is not actually caused by  type A or type B influenza. Studies show that less than 25 percent of suspected ILI cases turn out to be influenza after lab testing. There are many other respiratory infections that look like influenza but are caused by other types of viruses and bacteria.2.4

According to Sascha Ellington, PhD, leader of the CDC’s influenza prevention and control team, the 42 percent influenza vaccine effectiveness rate falls within the “range” that the CDC “typically” sees when the vaccine is a “good match with the [influenza] viruses that are circulating.” This season’s rate thus far lags behind the estimated 54 percent effectiveness rate for the flu shot in 2022-2023, but it is better than the 36 percent rate for 2021-2022.1 2 3 5 6

Keep reading

Veterans Affairs Kept COVID-19 Vaccine Mandate In Place Without Evidence

The U.S. Department of Veterans Affairs (VA) reviewed no data when deciding in 2023 to keep its COVID-19 vaccine mandate in place.

VA Secretary Denis McDonough said on May 1, 2023, that the end of many other federal mandates “will not impact current policies at the Department of Veterans Affairs.”

He said the mandate was remaining for VA health care personnel “to ensure the safety of veterans and our colleagues.”

Mr. McDonough did not cite any studies or other data. A VA spokesperson declined to provide any data that was reviewed when deciding not to rescind the mandate. The Epoch Times submitted a Freedom of Information Act for “all documents outlining which data was relied upon when establishing the mandate when deciding to keep the mandate in place.”

The agency searched for such data and did not find any.

“The VA does not even attempt to justify its policies with science, because it can’t,” Leslie Manookian, president and founder of the Health Freedom Defense Fund, told The Epoch Times.

“The VA just trusts that the process and cost of challenging its unfounded policies is so onerous, most people are dissuaded from even trying,” she added.

The VA’s mandate remains in place to this day.

Keep reading

Hospital Pays Job Applicant Who Refused Mandated Flu Shot

A hospital in Grand Rapids, Mich., has agreed to pay a settlement to a job applicant who had been offered a position, but then was arbitrarily rejected because he declined to take a flu shot hospital officials demanded.

News of the settlement comes from Liberty Counsel.

The fight involved Trinity Health Grand Rapids, which previously was known as Mercy Health St. Mary’s. The resolution includes a consent decree that allows paying of some $50,000 to the worker who was rejected.

The case originally was filed by the U.S. Equal Employment Opportunity Commission and charged the hospital improperly denied a job applicant’s request for a religious exemption to the flu shot.

The requirement for such shots later was dropped by the hospital, which agreed to train leaders on religious rights in addition to paying the settlement.

“According to the EEOC’s lawsuit, even though the hospital’s former flu shot policy allowed for a religious exemption, the hospital determined the applicant’s articulated religious beliefs were ‘insufficient’ to grant the exemption and denied it without an explanation. Trinity Health, which had made a conditional job offer to the applicant, then rescinded that job offer and did not give the applicant an opportunity to address the concerns with his request.”

The EEOC accused the corporation of violating Title VII of the Civil Rights Act of 1964.

The report explained federal law insists that employers make reasonable accommodations for religious employees – unless those accommodations create an “undue hardship” on the company.

Keep reading

34 Deaths, 302 Serious Injuries: RSV Vaccines Aren’t Even a Year Old but Some Experts Say It’s Time to Pull Them From the Market

It’s been less than a year since the Centers for Disease Control and Prevention (CDC) recommended two new respiratory syncytial virus (RSV) vaccines — yet CDC data and the Vaccine Adverse Event Reporting System (VAERS) already show reports of 34 deaths, 302 serious adverse events and according to news reports this week, a safety signal for Guillain-Barré syndrome (GBS).

Reported cases include several instances of severe adverse events in newborns, including the death of a 27-day-old baby who was wrongly administered the vaccine, and in pregnant women and people in age groups for which the RSV vaccines were not approved.

The U.S. Food and Drug Administration (FDA) approved Pfizer’s Abrysvo and GSK’s Arexvy RSV vaccines for adults ages 60 and older — but not for children or babies.

Abrysvo is also approved for pregnant women, targeting RSV prevention in babies. The FDA approved Abrysvo and Arexvy in May 2023.

According to CDC data, approximately 9.65 million RSV vaccine doses — 6.58 million Arexvy doses and 3.06 million Abrysvo doses — were administered as of Feb. 16.

Members of the CDC’s Advisory Committee on Immunization Practices (ACIP) presented the data on deaths and adverse events related to the RSV vaccines at a Feb. 29 meeting.

Yet, ACIP — and news media reports — primarily focused on GBS safety signals, glossing over deaths and the administration of the vaccines to unauthorized age groups.

Instead, CDC officials claimed it’s too early to determine if the RSV vaccines caused the adverse events and reiterated that the shots are safe, according to The Associated Press (AP).

Experts who spoke with The Defender disputed the CDC’s reassurances. Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense (CHD), said “34 deaths in 10 months should be sufficient to pull the RSV vaccines from the market. But the FDA will not do that — nor will there be full investigations regarding these deaths.”

“I am greatly concerned with the excessive application of the RSV vaccine,” said cardiologist Dr. Peter McCullough. “We are beginning to see the tip of the iceberg in terms of serious side effects.”

Keep reading

Health Officials Concerned Over Possible RSV Vaccine Link To Rare Neurological Condition

“Trust the science,” they told us… 

At a time when the largest mRNA Covid vaccine peer-reviewed study recently revealed increases in neurological, blood, and heart-related conditions, along with the pharma-industrial complex unleashing a ‘blitzkrieg’ of vaccine commercials across corporate media outlets, a new report has found that vaccines for respiratory syncytial virus could be causing a rare nervous system disorder in older adults. 

The New York Times has reported that new safety data for two RSV vaccines, presented at a meeting of scientific advisers to the Centers for Disease Control and Prevention on Thursday, indicates that Guillain-Barre syndrome – a rare condition where the immune system attacks nerve cells, leading to muscle weakness and paralysis – may have occurred in adults over 60 who received the vaccines. Two vaccines, Pfizer’s Abrysvo and GSK’s Arexvy, are currently available on the market.

Officials said the rare disease that attacks the immune system was found in two cases per 100,000 vaccinated, and added more data is needed to understand the risks. 

“At this point, due to the uncertainties and limitations, these early data cannot establish if there is an increased risk for GBS after vaccination in this age group,” Dr. Thomas Shimabukuro, director of the CDC’s Immunization Safety Office, said at the meeting on Thursday. 

Dr. Shimabukuro continued: Increased surveillance “will be better able to determine if an increased risk for GBS after RSV vaccination is present, and if so the magnitude of the risk.” 

NYTimes pointed out the new safety data was derived from multiple databases maintained by federal health agencies: 

“Of 37 preliminary reports in the Vaccine Adverse Event Reporting System, officials verified 23 by medical record review, 15 with Abrysvo and eight after Arexvy, Dr. Shimabukuro said. There were nearly three additional cases of GBS per million doses of Abrysvo than would be expected in the population of older Americans.

“A separate database identified four cases of GBS linked to Arexvy, translating to an estimated 14 cases per million doses administered. That system did not pick up any cases after shots of Abrysvo. But the vaccine accounted for only about 10 percent of the total doses recorded in the database.” -NYTimes

“I will say that these rates are higher than rates that we’ve observed for high-dose influenza and for Shingrix,” Dr. Shimabukuro said.

NYTimes also noted, “Additional data from the Centers for Medicare & Medicaid Services indicated that the incidence of Guillain-Barré syndrome after vaccination with Abrysvo was roughly five times higher than would be expected. The incidence after vaccination with Arexvy was not statistically significant.” 

A GSK spokeswoman told the media outlet, “There are limitations to all of these data, and further analysis by FDA, CDC and the vaccine manufacturers are needed to confirm and quantify any potential risk.” 

Keep reading

‘Stunning Act of Scientific Censorship’: Journal Retracts Peer-Reviewed Study Critiquing COVID-19 Vaccine

The journal Cureus on Monday retracted the first peer-reviewed paper to provide an extensive analysis of COVID-19 mRNA vaccine trial data and post-injection injuries. The authors of the paper also called for a global moratorium on the vaccines.

Dr. Peter McCullough, one of the paper’s authors, called the retraction “a stunning act of scientific censorship.” He told The Defender:

“The journal and its editors had the right to reject the paper at any time during the review process. Once published, it is a violation of the Committee on Publication Ethics (COPE) Guidelines to retract a paper without adequate justification.”

The paper, published last month, detailed the vaccines’ potential serious harms to humans, vaccine control and processing issues, the mechanisms behind adverse events, the immunological reasons for vaccine inefficacy and the mortality data from the registrational trials.

The authors concluded:

“Federal agency approval of the COVID-19 mRNA injectable products on a blanket-coverage population-wide basis had no support from an honest assessment of all relevant registrational data and commensurate consideration of risks versus benefits.”

They also called for the vaccines to be immediately removed from the Centers for Disease Control and Prevention’s (CDC) childhood immunization schedule and for the boosters to be suspended.

The paper was read more than 350,000 times in the month after it was posted. An average Cureus paper has only approximately 2,700 views in an entire year.

Keep reading

Childhood Vaccine Schedule Led To ‘Greatest Decline In Public Health In Human History’

Public health agencies have refused to study or to publicly release data comparing the health outcomes of vaccinated and unvaccinated children, according to experts who spoke during Monday’s Senate roundtable discussion on “Federal Health Agencies and the COVID Cartel.”

The roundtable, hosted by Sen. Ron Johnson, also focused on COVID-19 vaccine contamination, the development of COVID-19 vaccines as part of bioweapons research and on censorship of journalists and scientists.

Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense (CHD), participated in the roundtable. He told The Defender that the corruption of public health agencies was an “issue [that] came up again and again, with solid data,” during the roundtable.

Hooker, who also appeared on Steve Bannon’s “War Room” on Monday to discuss how the current childhood vaccination schedule is harmful to children’s health, said CHD’s presence at the roundtable was important.

“It was very significant for CHD to have a seat at the table at the briefing and also significant how much Sen. Johnson knew of and appreciated our work,” he said. “We have a much wider reach than we give ourselves credit for and I believe we’ll get more such invitations to speak to and influence congressional representatives.”

“Sen. Johnson and several others are highly energized regarding the woeful pandemic response, including the society-wide release of mRNA technology, with an astounding increase in vaccine adverse events,” Hooker added.

Keep reading

Iraq War veteran in his late 30s claims COVID vaccine gave him condition that causes full body paralysis, with medical records updated to say vaccine injury is cause after doctors tried to blame it on flu

An Iraq War veteran has claimed the Covid-19 vaccine made him develop Guillain-Barre Syndrome causing full body paralysis and leaving him with nerve damage.

Drew – who prefers not to share his last name – says he was an ‘otherwise healthy 36-year-old’ before he received the mRNA Pfizer vaccine in April 2021. 

After two doses, he says he started experiencing ‘cold/flu symptoms’ which ‘turned to numbness, tingling’ and then to ‘complete paralysis within weeks’.

He says he was hospitalized and diagnosed with Guillain-Barre syndrome, a very rare progressive nerve disorder that can cause total body paralysis in serious cases. Most people make a full recovery.

He says doctors did not link his illness to the vaccine at first, but claims his medical records have now been updated to show he had a ‘vaccine injury.’ DailyMail.com has requested to see a copy of said records. 

Now back at home, Drew says he is raising awareness of vaccine side effects and says he ‘still can’t walk without assistance’. 

Drew signed up for the army straight after high school and shortly after was deployed in Operation Iraqi Freedom. 

On a fundraising page for his medical bills, it says: ‘After a four year break in service he wanted to continue to serve his country and community in the MN, enlisting in the National Guard. 

‘Then in 2018, he was deployed again, this time to Kuwait/Middle East.’

After that he retired from the army and took a job in sales just in time for the birth of his son. 

Then he says he got a call from Veterans Affairs encouraging him to get the vaccine and telling him ‘it would prevent illness and prevent transmission to elderly mother.’

He told Alpha News: ‘It was done in the atrium … they had some cubicles, and I just went in, sat down and got it. There wasn’t a lot of information. They weren’t really telling me anything. 

‘It was just kind of like the basic training assembly line for vaccines on deployment.’

He said he had flu-like symptoms for a few days which then turned to ‘numbness, tingling, my hands, my feet, my toes’. 

Keep reading